Skip to content

Virtual Reality in Postoperative Acute Pain Management in Thoracic Surgery

Virtual Reality in Postoperative Acute Pain Management in Thoracic Surgery (VRThx)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06097520
Acronym
VRThx
Enrollment
39
Registered
2023-10-24
Start date
2023-11-29
Completion date
2025-02-24
Last updated
2025-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain

Keywords

thoracic surgery, Virtual reality (VR)

Brief summary

This randomized controlled study is to investigate the effectiveness of VR headsets in reducing postoperative pain intensity among patients after having undergone thoracic surgical procedures.

Detailed description

Thoracic surgical procedures can often result in postoperative pain. Traditional methods of pain management, such as medication, have limitations in terms of their efficacy and potential side effects. Therefore, there is a need for alternative approaches that can effectively alleviate postoperative pain while minimizing medication use. Virtual reality (VR) technology has gained attention as a potential non-pharmacological intervention for pain management. There is limited research specifically focusing on the use of VR in the context of thoracic surgery. This study is to investigate the effectiveness of VR headsets in reducing postoperative pain intensity among patients after having undergone thoracic surgical procedures. To enhance the objectivity of the investigation, objective parameters alongside subjective assessments of pain will be incorporated. While self-reported measures are valuable, they can be subjective and influenced by individual perception. Therefore, the subjective assessments will be complemented by objective measurements to gain a more comprehensive understanding of the pain experience and its modulation through the VR intervention.

Interventions

For the VR Intervention a VR head-mounted display, the Pico G2 4K, will be used. This intervention involves wearing VR glasses and experiencing non-interactive videos with sound through a headset. The footage consists of different immersive 360-degree scenarios from natural environments (e.g., forest), while corresponding sounds, meditation or classical music harmoniously tuned to these scenarios and are played through noise-cancelling headphones.

Sponsors

University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

investigator-initiated, single-center, randomized controlled study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients ≥18 years * Written informed consent as documented by signature from the patient * Video-assisted anatomical resection of the lung (VATS) (Surgery duration of at least 90 minutes) * Ability to speak, understand and read German

Exclusion criteria

* Significant mental, cognitive or neurological impairments (Delirium, psychoses, unstable dissociative disorders, any form of organic brain disorder, …) * Inability to follow the study procedures (e.g., due to language problems, visual and hearing impairments) * Chronic pain * Morphine intolerance * Excessive alcohol consumption (men \> 3 standard drinks, women \> 2 standard drinks per day) * Substance abuse * Unable or not willing to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Change in postoperative pain intensity levelAt first, second and third postoperative day: before the inhalation procedure, immediately after the inhalation and 15 minutes after the inhalation procedurePain intensity will be measured using the Numeric Rating Scale (NRS). The numerical scale is most commonly 0 to 10, with 0 being no pain and 10 being the worst pain imaginable.

Secondary

MeasureTime frameDescription
Opioid Consumption3 postoperative daysOpioid consumption will be documented in both groups

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026